---
schema_version: "secwatch.filing_event.v1"
accession: "0001641489-23-000076"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2023-11-15T23:59:59+00:00"
generated_at: "2026-06-08T02:29:28.116595+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics approves 1-for-40 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split effective 4:01 PM ET on Nov 20, 2023; post-split trading begins Nov 21.
- Ratio 1-for-40 applies equally to Class A and Class B common stock; fractional shares rounded up.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.
- CUSIP for post-split Class A common stock: 91835204; proportionate ownership unchanged.

## SEC filing metadata
- accession: 0001641489-23-000076
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2023-11-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000076/0001641489-23-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000164148923000076/vtvt-20231114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641489-23-000076
- JSON: https://secwatch.observer/filing/0001641489-23-000076.json
- Plain text: https://secwatch.observer/filing/0001641489-23-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.